Annual report pursuant to Section 13 and 15(d)

SEGMENTS (Details)

v3.21.1
SEGMENTS (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Revenues $ 42,219,783 $ 29,349,083
Cost of product revenue 61,291,426 39,504,238
Loss from operations (64,914,877) (41,424,327)
Interest and other expense, net (128,528) (227,322)
Loss/Gain on the extinguishment of debt 991,797 (9,962,495)
Net loss (75,748,548) (48,279,317)
Depreciation and amortization expense 3,942,292 3,258,148
TOTAL ASSETS 207,673,394 127,090,725
ADMA BioManufacturing    
Revenues 36,673,287 22,176,699
Cost of product revenue 55,908,696 33,306,858
Loss from operations (46,904,634) (29,360,522)
Interest and other expense, net (984,017) (1,091,993)
Gain on transfer of plasma center assets   0
Loss/Gain on the extinguishment of debt 0 0
Net loss (47,888,651) (30,452,515)
Capital expenditure 7,579,437 3,772,742
Depreciation and amortization expense 3,341,506 2,789,498
TOTAL ASSETS 140,908,957 100,461,050
Plasma Collection Centers    
Revenues 5,403,662 7,029,550
Cost of product revenue 5,382,730 6,197,380
Loss from operations (4,410,890) (1,337,459)
Interest and other expense, net (7,388) 13,521
Gain on transfer of plasma center assets   11,527,421
Loss/Gain on the extinguishment of debt 0 0
Net loss (4,418,278) 10,203,483
Capital expenditure 5,147,243 39,096
Depreciation and amortization expense 591,593 455,412
TOTAL ASSETS 13,102,008 3,967,860
Corporate    
Revenues 142,834 142,834
Cost of product revenue 0 0
Loss from operations (13,599,353) (10,726,346)
Interest and other expense, net (10,834,063) (7,341,444)
Gain on transfer of plasma center assets   0
Loss/Gain on the extinguishment of debt 991,797 (9,962,495)
Net loss (23,441,619) (28,030,285)
Capital expenditure 0 0
Depreciation and amortization expense 9,193 13,238
TOTAL ASSETS 53,662,429 22,661,815
Consolidated (member)    
Revenues 42,219,783 29,349,083
Cost of product revenue 61,291,426 39,504,238
Loss from operations (64,914,877) (41,424,327)
Interest and other expense, net (11,825,468) (8,419,916)
Gain on transfer of plasma center assets   11,527,421
Loss/Gain on the extinguishment of debt 991,797 (9,962,495)
Net loss (75,748,548) (48,279,317)
Capital expenditure 12,726,680 3,811,838
Depreciation and amortization expense 3,942,292 3,258,148
TOTAL ASSETS $ 207,673,394 $ 127,090,725